NCT01670292

Brief Summary

This is a biomechanical study which is Project 1 in the Developmental Center for Clinical and Translational Research in Chiropractic (DCRC I) (NIH/NCCAM grant 1 U19 AT004663-01; principal investigator Christine Goertz, DC, PhD). This study is designed to monitor both physiological and patient self-report outcome variables. In addition, as there is little quantitative information on Spinal Manipulation Technique procedures reported in clinical trials, the study is designed to collect preliminary kinetic measures of the spinal manipulation technique delivery (i.e. force-time profiles).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable low-back-pain

Timeline
Completed

Started Sep 2012

Typical duration for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 2, 2012

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 22, 2012

Completed
10 days until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

December 5, 2017

Completed
Last Updated

December 5, 2017

Status Verified

October 1, 2017

Enrollment Period

1.7 years

First QC Date

August 2, 2012

Results QC Date

April 17, 2017

Last Update Submit

October 25, 2017

Conditions

Keywords

Low Back Pain

Outcome Measures

Primary Outcomes (4)

  • Patient-Centered Outcome Measurement Mean Change After 6 Weeks (VAS, RMDQ)

    VAS - Visual Analog Scale - Scale: 0-100 mm (anchors: 0 mm = No Pain, 100 mm = Worst Imaginable Pain). VAS Interpretation: A higher score indicates greater pain intensity. In this study, improvement of 30% from the baseline value was considered clinically significant. RMDQ - Roland Morris disability questionnaire - Scale: 0 (no disability) to 24 (maximum disability). RMDQ Interpretation: Greater levels of disability are reflected by higher scores. In this study, improvement of 30% from the baseline value was considered clinically significant.

    Baseline to 6 weeks

  • Lumbar-spine Stiffness (LSS)

    LSS\* contains 5 variables: global stiffness (GS, unit: Newton/mm) at L3 from 1) hand palpation 2) a hand-held device \& 3) an automated indenter device; global stiffness variation (GSV, unit: Newton/mm) between GS from L1 to L5 from 4) hand palpation \& 5) a hand-held device. \*LSS Interpretation: The values of the outcome depend on testing procedure, instruction to participants, and equipment. Currently there is no consensus regarding what value is high than normal, normal, lower than normal.

    Baseline, 2 weeks, 6 weeks

  • Lumbar-spine Stiffness (LSS) - Normalized Global Stiffness Variation

    LSS contains 2 variables: Palpatory and Handheld device - normalized global stiffness variation (nGSV, unitless). LSS Interpretation: The values of the outcome depend on testing procedure, instruction to participants, and equipment. Currently there is no consensus regarding what value is higher than normal, normal, lower than normal.

    Baseline, 2 weeks, 6 weeks

  • Flexion-Relaxation Ratio (FRR)

    FRR contains 4 variables, which are the average right and left back muscle FRR obtained using 1) maximum EMG during flexion, and 2) maximum EMG during extension to normalize EMG during full flexion; and asymmetry between the right and left back muscle FRRs using 3) maximum EMG during flexion, and 4) maximum EMG during extension to normalize EMG during full flexion FRR Interpretation: The values of the outcome depend on testing procedure, instruction to participants, and equipment. Currently there is no consensus regarding what value is high than normal, normal, lower than normal.

    Baseline, 2 weeks, 6 weeks

Secondary Outcomes (7)

  • Kinetic Measure - Spinal Segment Load (SSL) Force

    6 weeks

  • Kinetic Measure - Spinal Segment Load (SSL) Moment

    6 weeks

  • Kinetic Measure - Spinal Segment Load (SSL) Rate of Loading for Force

    6 weeks

  • Kinetic Measure - Spinal Segment Load (SSL) Rate of Loading for Moment

    6 weeks

  • PROMIS-29 - Patient Reported Outcomes Measurement Information Scale-29: General Health Status Scale

    Baseline, 2 weeks, 6 weeks

  • +2 more secondary outcomes

Study Arms (1)

Experimental: HVLA-SM

OTHER

Experimental High Velocity Low Amplitude Spinal Manipulation

Other: HVLA-SM

Interventions

HVLA-SMOTHER

High Velocity Low Amplitude Spinal Manipulation

Experimental: HVLA-SM

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • NRS score, AVERAGE within the past 24 hours
  • Must be ≥4 at the phone screen or baseline 1 visit
  • Must be ≥2 at phone screen, baseline 1 and baseline 2 visits
  • Roland Morris Disability ≥6
  • Age 21-65
  • Signed informed consent document
  • Chronic (12+ weeks) low back pain

You may not qualify if:

  • Compliance concerns
  • No manipulable lesion in L1-L5 or SI joints
  • The absence of typical palpatory characteristics as well as the absence of a global assessment that would indicate that spinal manipulation is likely to generate a positive therapeutic effect, even without the presence of standard palpatory findings
  • Ongoing treatment for low back pain by outside provider
  • Comorbid conditions
  • Serious concomitant illness
  • Inflammatory or destructive spinal tissue change
  • Ankylosing Spondylytis
  • Fibromyalgia
  • Rheumatoid Arthritis
  • Confirmed or suspected disc herniation with neurological signs
  • Neuromuscular disease (e.g. Parkinson's, Muscular Dystrophy, Cerebral Palsy, or Myasthenia gravis
  • Spinal surgery \<6 months
  • Suspicion of drug or alcohol dependence or abuse
  • Uncontrolled hypertension
  • +31 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Palmer College of Chiropractic

Davenport, Iowa, 52803, United States

Location

Related Publications (3)

  • Xia T, Wilder DG, Gudavalli MR, DeVocht JW, Vining RD, Pohlman KA, Kawchuk GN, Long CR, Goertz CM. Study protocol for patient response to spinal manipulation - a prospective observational clinical trial on physiological and patient-centered outcomes in patients with chronic low back pain. BMC Complement Altern Med. 2014 Aug 8;14:292. doi: 10.1186/1472-6882-14-292.

    PMID: 25106673BACKGROUND
  • Minkalis AL, Vining RD. What is the pain source? A case report of a patient with low back pain and bilateral hip osteonecrosis. J Can Chiropr Assoc. 2015 Sep;59(3):300-10.

    PMID: 26500365BACKGROUND
  • Xia T, Long CR, Vining RD, Gudavalli MR, DeVocht JW, Kawchuk GN, Wilder DG, Goertz CM. Association of lumbar spine stiffness and flexion-relaxation phenomenon with patient-reported outcomes in adults with chronic low back pain - a single-arm clinical trial investigating the effects of thrust spinal manipulation. BMC Complement Altern Med. 2017 Jun 9;17(1):303. doi: 10.1186/s12906-017-1821-1.

Related Links

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Ting Xia
Organization
Palmer Center for Chiropractic Research

Study Officials

  • Ting Xia, PhD

    Palmer College of Chiropractic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 2, 2012

First Posted

August 22, 2012

Study Start

September 1, 2012

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

December 5, 2017

Results First Posted

December 5, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will share

Once the resulting manuscripts have been published, data sets will be provided for public access. Potential investigators can contact one of the Co-PIs to present their hypothesis, study design, instruments and/or data on which to focus, and resources required. Depending upon the needs and desires of the requesting party, the data that are shared may include analytic tables or de-identified or limited data sets that are transmitted to the requesting parties for additional analyses.

Locations